Neoadjuvant Chemotherapy in Oesophageal Adenocarcinoma

The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(17)30813-6
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Elsevier BV

Related search

Neoadjuvant Chemotherapy in Oesophageal Adenocarcinoma – Authors' Reply

The Lancet Oncology
Oncology
2017English

Assessment of Histopathological Response in Gastric and Gastro-Oesophageal Junction Adenocarcinoma Following Neoadjuvant Chemotherapy: Which Scoring System to Use?

ISRN Pathology
2012English

New Developments in Oesophageal Adenocarcinoma Treatment

European Oncology and Haematology
OncologyHematology
2008English

Neoadjuvant Chemoradiotherapy or Chemotherapy for Gastroesophageal Junction Adenocarcinoma: A Systematic Review and Meta-Analysis

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

Neoadjuvant Chemotherapy in Breast Cancer

English

Neoadjuvant Chemotherapy: Role in Breast Cancer

2013English

GATA6 Expression in Barrett's Oesophagus and Oesophageal Adenocarcinoma

Digestive and Liver Disease
HepatologyGastroenterology
2015English

PTU-159 Characterisation of Oesophageal Muc1 Expression in the Progression to Oesophageal Adenocarcinoma

Gut
Gastroenterology
2013English

Locally Advanced Esophageal Adenocarcinoma: Response to Neoadjuvant Chemotherapy and Survival Predicted By[18F]FDG-Pet/Ct

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy